A reappraisal of current hypotheses concerning the possible roles of amylin in physiology, pathology and therapeutics.
Cooper
G J
GJ
Biochemistry and Molecular Biology Group, School of Biological Sciences, University of Auckland, New Zealand.
D000682:Amyloid / Q000502:physiology* / Q000627:therapeutic use; D000818:Animals; D003920:Diabetes Mellitus / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D005246:Feedback; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance / Q000502:physiology; D058228:Islet Amyloid Polypeptide; D007515:Islets of Langerhans / Q000502:physiology; D009765:Obesity / Q000503:physiopathology; D051381:Rats
D000682:Amyloid; D007328:Insulin; D058228:Islet Amyloid Polypeptide